Gene · 683
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Streptococcus pyogenes can support or inhibit growth of Haemophilus influenzae by supplying or restricting extracellular NAD. | PLoS One | 2022 | 36170255 | PubTator, text mining | PubMed |
| MAO-B Polymorphism Associated with Progression in a Chinese Parkinson's Disease Cohort but Not in the PPMI Cohort. | Parkinsons Dis | 2022 | 36164437 | PubTator, text mining | PubMed |
| Apprehending the NAD+-ADPr-Dependent Systems in the Virus World. | Viruses | 2022 | 36146784 | PubTator, text mining | PubMed |
| Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 36142442 | PubTator, text mining | PubMed |
| Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies. | Antioxidants (Basel) | 2022 | 36139711 | PubTator, text mining | PubMed |
| Assessment of a Large-Scale Unbiased Malignant Pleural Effusion Proteomics Study of a Real-Life Cohort. | Cancers (Basel) | 2022 | 36139528 | PubTator, text mining | PubMed |
| Paracrine ADP Ribosyl Cyclase-Mediated Regulation of Biological Processes. | Cells | 2022 | 36078044 | PubTator, text mining | PubMed |
| Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer. | Cells | 2022 | 36078035 | PubTator, text mining | PubMed |
| NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets. | Int J Mol Sci | 2022 | 36077374 | PubTator, text mining | PubMed |
| GBA1 and The Immune System: A Potential Role in Parkinson's Disease? | J Parkinsons Dis | 2022 | 36057834 | PubTator, text mining | PubMed |
| Bioinformatics analysis to obtain critical genes regulated in subcutaneous adipose tissue after bariatric surgery. | Adipocyte | 2022 | 36036283 | PubTator, text mining | PubMed |
| Integrated Approaches to Identify miRNA Biomarkers Associated with Cognitive Dysfunction in Multiple Sclerosis Using Text Mining, Gene Expression, Pathways, and GWAS. | Diagnostics (Basel) | 2022 | 36010264 | PubTator, text mining | PubMed |
| Addressing the Neuroprotective Actions of Coffee in Parkinson's Disease: An Emerging Nutrigenomic Analysis. | Antioxidants (Basel) | 2022 | 36009304 | PubTator, text mining | PubMed |
| Splicing QTL analysis focusing on coding sequences reveals mechanisms for disease susceptibility loci. | Nat Commun | 2022 | 36002455 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis of rabbit interscapular brown adipose tissue whitening under physiological conditions. | Adipocyte | 2022 | 36000239 | PubTator, text mining | PubMed |
| NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity. | Proc Natl Acad Sci U S A | 2022 | 35994674 | PubTator, text mining | PubMed |
| Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain. | Proc Natl Acad Sci U S A | 2022 | 35994671 | PubTator, text mining | PubMed |
| Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson's disease. | Mol Neurodegener | 2022 | 35978378 | PubTator, text mining | PubMed |
| Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis. | PLoS One | 2022 | 35976971 | PubTator, text mining | PubMed |
| Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium. | Neurology | 2022 | 35970579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/683/papers?page=10